Phase 3 Readout~month
Phase 3 Topline: A Single-Arm Open-Label Multi-Centre Extension Study of Pertuzumab Administered As a Single Agent or
- Drug
- pertuzumab
- Indication
- Solid Tumors
Other upcoming events for ENTA
Phase 1 StartPhase 1 Start: A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK)
Phase 3 ReadoutPhase 3 Topline: A Randomized, Open Label, Phase III Trial to Evaluate the Efficacy and Safety of Palbociclib + Anti-
Phase 3 ReadoutPhase 3 Topline: Comparison of Efficacy of Tranexamic Acid Versus Vasopressin in Blood Loss Among Placenta Previa Pat
Phase 3 ReadoutPhase 3 Topline: A Phase 3, Multicenter, Randomized, Placebo- and Active Comparator-Controlled Study Evaluating the E
Phase 3 ReadoutPhase 3 Topline: A Randomized, Open, Multicenter Phase III Clinical Trial of Combination of Sintilimab Injection (IBI
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.